EG-VEGF controls placental growth and survival in normal and pathological pregnancies: Case of fetal growth restriction (FGR)

Cellular and Molecular Life Sciences

Volumn 70, Issue 3, 2013, Pages 511-525

  Brouillet, S ^a,b   Murthi, P ^g,h   Hoffmann, P ^a,b,c   Salomon, A ^a,b   Sergent, F ^a,b   De Mazancourt, P ^e   Dakouane Giudicelli, M ^e   Dieudonne M N ^e   Rozenberg, P ^e   Vaiman, D ^d   Barbaux, S ^d   Benharouga, M ^a,b,f   Feige, J J ^a,b   Alfaidy, N ^a,b  

^a CEA GRENOBLE   (France)

^b UNIV GRENOBLE ALPES   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d INSTITUT COCHIN   (France)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^f CNRS   (France)

^g ROYAL WOMEN'S HOSPITAL   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiogenesis; EG VEGF; FGR; Placenta; Prokineticin

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; KI 67 ANTIGEN; MESSENGER RNA; PROKINETICIN RECEPTOR 1; PROKINETICIN RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CHORION VILLUS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HLX GENE; HOMEOBOX; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MALE; NEWBORN; PLACENTA DEVELOPMENT; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL; SYNCYTIUM; TROPHOBLAST;

CELL HYPOXIA; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FETAL GROWTH RETARDATION; GIANT CELLS; HOMEODOMAIN PROTEINS; HUMANS; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TROPHOBLASTS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED;

EID: 84872336052     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1141-z     Document Type: Article

References (61)

1. Cross JC, Baczyk D, Dobric N, Hemberger M, Hughes M, Simmons DG, Yamamoto H, Kingdom JC (2003) Genes, development and evolution of the placenta. Placenta 24(2-3):123-130
2. Henriksen T (1999) Foetal nutrition, foetal growth restriction and health later in life. Acta Paediatr Suppl 88(429):4-8
3. Barker DJ (1992) Fetal growth and adult disease. Br J Obstet Gynaecol 99(4):275-276
4. Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A (2000) Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 182(1 Pt 1):198-206
5. Baschat AA (2004) Fetal responses to placental insufficiency: an update. BJOG 111(10):1031-1041. doi:10.1111/j.1471-0528. 2004.00273.x
6. Bullock CM, Li JD, Zhou QY (2004) Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists. Mol Pharmacol 65(3):582-588. doi:10.1124/mol.65.3.582
7. Pollack RN, Divon MY (1992) Intrauterine growth retardation: definition, classification, and etiology. Clin Obstet Gynecol 35(1):99-107
8. Regnault TR, Galan HL, Parker TA, Anthony RV (2002) Placental development in normal and compromised pregnancies-a review. Placenta 23(Suppl A):S119-S129. doi:10.1053/plac.2002. 0792
9. Sibley CP, Turner MA, Cetin I, Ayuk P, Boyd CA, D'Souza SW, Glazier JD, Greenwood SL, Jansson T, Powell T (2005) Placental phenotypes of intrauterine growth. Pediatr Res 58(5):827-832. doi:10.1203/01.PDR.0000181381.82856.23
10. Krebs C, Macara LM, Leiser R, Bowman AW, Greer IA, Kingdom JC (1996) Intrauterine growth restriction with absent enddiastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol 175(6):1534-1542
11. Kingdom J, Huppertz B, Seaward G, Kaufmann P (2000) Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 92(1):35-43
12. Kingdom JC, Kaufmann P (1999) Oxygen and placental vascular development. Adv Exp Med Biol 474:259-275
13. Smith SC, Baker PN, Symonds EM (1997) Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 177(6):1395-1401
14. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA (2000) Placental apoptosis in preeclampsia. Obstet Gynecol 96(2):271-276
15. DiFederico E, Genbacev O, Fisher SJ (1999) Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 155(1):293-301. doi: 10.1016/S0002-9440(10)65123-1
16. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T (2002) Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 186(1):158-166
17. Levy R, Nelson DM (2000) To be, or not to be, that is the question. Apoptosis in human trophoblast. Placenta 21(1):1-13. doi:10.1053/plac.1999.0450
18. Mayhew TM, Ohadike C, Baker PN, Crocker IP, Mitchell C, Ong SS (2003) Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta 24(2-3):219-226
19. Khong TY, De Wolf F, Robertson WB, Brosens I (1986) Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 93(10):1049-1059
20. Arroyo JA, Winn VD (2008) Vasculogenesis and angiogenesis in the IUGR placenta. Semin Perinatol 32(3):172-177. doi:10.1053/ j.semperi.2008.02.006
21. Torry DS, Hinrichs M, Torry RJ (2004) Determinants of placental vascularity. Am J Reprod Immunol 51(4):257-268. doi:10.1111/ j.1600-0897.2004.00154.x
22. Chen CP, Bajoria R, Aplin JD (2002) Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. Am J Obstet Gynecol 187(3):764-769
23. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ (1997) Regulation of human placental development by oxygen tension. Science 277(5332):1669-1672
24. Burton GJ, Jauniaux E, Watson AL (1999) Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am J Obstet Gynecol 181(3):718-724
25. Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365(9461):785-799. doi:10.1016/S0140-6736(05)17987-2
26. Jarvenpaa J, Vuoristo JT, Savolainen ER, Ukkola O, Vaskivuo T, Ryynanen M (2007) Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction. Gynecol Endocrinol 23(6):351-355. doi: 10.1080/09513590701350291
27. Roh CR, Budhraja V, Kim HS, Nelson DM, Sadovsky Y (2005) Microarray-based identification of differentially expressed genes in hypoxic term human trophoblasts and in placental villi of pregnancies with growth restricted fetuses. Placenta 26(4):319-328. doi:10.1016/j.placenta.2004.06.013
28. McCarthy C, Cotter FE, McElwaine S, Twomey A, Mooney EE, Ryan F, Vaughan J (2007) Altered gene expression patterns in intrauterine growth restriction: potential role of hypoxia. Am J Obstet Gynecol 196(1):70 e71-76. doi:10.1016/j.ajog.2006. 08.027
29. Cartwright JE, Holden DP, Whitley GS (1999) Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide. Br J Pharmacol 128(1):181-189. doi: 10.1038/sj.bjp.0702757
30. Irving JA, Lala PK (1995) Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGFbeta, IGF-II, and IGFBP-1. Exp Cell Res 217(2):419-427. doi: 10.1006/excr.1995.1105
31. Lysiak JJ, Han VK, Lala PK (1993) Localization of transforming growth factor alpha in the human placenta and decidua: role in trophoblast growth. Biol Reprod 49(5):885-894
32. Chui A, Tay C, Cocquebert M, Sheehan P, Pathirage NA, Donath S, Fournier T, Badet J, Evain-Brion D, Brennecke SP, Kalionis B, Murthi P (2012) Homeobox gene Distal-less 3 is a regulator of villous cytotrophoblast differentiation and its expression is increased in human idiopathic foetal growth restriction. J Mol Med (Berlin, Germany) 90(3):273-284
33. Murthi P, Doherty V, Said J, Donath S, Brennecke SP, Kalionis B (2006) Homeobox gene HLX1 expression is decreased in idiopathic human fetal growth restriction. Am J Pathol 168(2):511-518
34. Murthi P, Said JM, Doherty VL, Donath S, Nowell CJ, Brennecke SP, Kalionis B (2006) Homeobox gene DLX4 expression is increased in idiopathic human fetal growth restriction. Mol Hum Reprod 12(12):763-769
35. Murthi P, So M, Gude NM, Doherty VL, Brennecke SP, Kalionis B (2007) Homeobox genes are differentially expressed in macrovascular human umbilical vein endothelial cells and microvascular placental endothelial cells. Placenta 28(2-3):219-223. doi:10.1016/j.placenta.2006.02.012
36. Rajaraman G, Murthi P, Brennecke SP, Kalionis B Homeobox gene HLX is a regulator of HGF/c-met-mediated migration of human trophoblast-derived cell lines. Biol Reprod 83(4):676-683
37. Rajaraman G, Murthi P, Leo B, Brennecke SP, Kalionis B (2007) Homeobox gene HLX1 is a regulator of colony stimulating factor-1 dependent trophoblast cell proliferation. Placenta 28(10):991-998
38. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, Peale F, Gurney A, Hillan KJ, Ferrara N (2001) Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412(6850):877-884. doi:10.1038/35091000
39. Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, Zhou QY (2002) Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J Biol Chem 277(22):19276-19280. doi:10.1074/jbc. M2021 39200
40. Brouillet S, Hoffmann P, Benharouga M, Salomon A, Schaal JP, Feige JJ, Alfaidy N (2010) Molecular characterization of EGVEGF-mediated angiogenesis: differential effects on microvascular and macrovascular endothelial cells. Mol Biol Cell 21(16):2832-2843. doi:10.1091/mbc.E10-01-0059
41. Hoffmann P, Feige JJ, Alfaidy N (2006) Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology 147(4):1675-1684. doi: 10.1210/en.2005-0912
42. Hoffmann P, Feige JJ, Alfaidy N (2007) Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation. Placenta 28(10):1049-1058. doi:10.1016/j.placenta.2007.03.008
43. Hoffmann P, Saoudi Y, Benharouga M, Graham CH, Schaal JP, Mazouni C, Feige JJ, Alfaidy N (2009) Role of EG-VEGF in human placentation: physiological and pathological implications. J Cell Mol Med 13(8B):2224-2235. doi:10.1111/j.1582-4934. 2008.00554.x
44. Brouillet S, Hoffmann P, Chauvet S, Salomon A, Chamboredon S, Sergent F, Benharouga M, Feige JJ, Alfaidy N (2012) Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors. Cell Mol Life Sci 69(9):1537-1550
45. Chen J, Kuei C, Sutton S, Wilson S, Yu J, Kamme F, Mazur C, Lovenberg T, Liu C (2005) Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1. Mol Pharmacol 67(6):2070-2076. Epub 2005 16
46. Frendo JL, Vidaud M, Guibourdenche J, Luton D, Muller F, Bellet D, Giovagrandi Y, Tarrade A, Porquet D, Blot P, Evain-Brion D (2000) Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome. J Clin Endocrinol Metab 85(10):3700-3707
47. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ (1999) Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 103(12):1641-1650. doi:10.1172/JCI6380
48. Genbacev O, Jensen KD, Powlin SS, Miller RK (1993) In vitro differentiation and ultrastructure of human extravillous trophoblast (EVT) cells. Placenta 14(4):463-475
49. Kisliouk T, Levy N, Hurwitz A, Meidan R (2003) Presence and regulation of endocrine gland vascular endothelial growth factor/ prokineticin-1 and its receptors in ovarian cells. J Clin Endocrinol Metab 88(8):3700-3707
50. Potgens AJ, Schmitz U, Bose P, Versmold A, Kaufmann P, Frank HG (2002) Mechanisms of syncytial fusion: a review. Placenta 23(Suppl A):S107-S113. doi:10.1053/plac.2002.0772
51. Frendo JL, Olivier D, Cheynet V, Blond JL, Bouton O, Vidaud M, Rabreau M, Evain-Brion D, Mallet F (2003) Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol Cell Biol 23(10):3566-3574
52. Blaise S, de Parseval N, Benit L, Heidmann T (2003) Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution. Proc Natl Acad Sci USA 100(22):13013-13018. doi: 10.1073/pnas.2132646100
53. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF III (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118(4):1567-1582
54. Morrish DW, Dakour J, LiH (1998) Functional regulation of human trophoblast differentiation. J Reprod Immunol 39(1-2):179-195
55. Shi QJ, Lei ZM, Rao CV, Lin J (1993) Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology 132(3):1387-1395
56. Douglas GC, King BF (1990) Differentiation of human trophoblast cells in vitro as revealed by immunocytochemical staining of desmoplakin and nuclei. J Cell Sci 96(Pt 1):131-141
57. Tanaka M, Natori M, Ishimoto H, Miyazaki T, Kobayashi T, Nozawa S (1994) Experimental growth retardation produced by transient period of uteroplacental ischemia in pregnant Sprague-Dawley rats. Am J Obstet Gynecol 171(5):1231-1234
58. Tapanainen PJ, Bang P, Wilson K, Unterman TG, Vreman HJ, Rosenfeld RG (1994) Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Pediatr Res 36(2):152-158
59. Zhou Y, Damsky CH, Fisher SJ (1997) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 99(9):2152-2164. doi: 10.1172/JCI119388
60. Fitzgerald B, Levytska K, Kingdom J, Walker M, Baczyk D, Keating S (2011) Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A. Placenta 32(4):339-345. doi:10.1016/ j.placenta.2011.01.018
61. Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, Silver R, Pergament E, Platt LD, Filkins K, Johnson A, Mahoney M, Hogge WA, Wilson RD, Mohide P, Hershey D, Wapner R (2004) Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 191(4):1452-1458. doi:10.1016/j.ajog. 2004. 05.068